Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000160559 | SCV000211138 | benign | Hereditary cancer-predisposing syndrome | 2014-07-07 | criteria provided, single submitter | clinical testing | The variant is found in HEREDICANCER,BR-OV-HEREDIC panel(s). |
Invitae | RCV000195736 | SCV000253129 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000160559 | SCV001351740 | likely benign | Hereditary cancer-predisposing syndrome | 2019-09-03 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001262554 | SCV001440475 | likely benign | Breast carcinoma | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000160559 | SCV002528611 | likely benign | Hereditary cancer-predisposing syndrome | 2022-02-11 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV001699048 | SCV002552488 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000160559 | SCV002700662 | benign | Hereditary cancer-predisposing syndrome | 2014-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003927527 | SCV004741955 | likely benign | MLH1-related disorder | 2019-06-11 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV001529186 | SCV001742227 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001529186 | SCV001797325 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001699048 | SCV001922878 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529186 | SCV001927854 | likely benign | not provided | no assertion criteria provided | clinical testing |